Kristen Gross
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 307 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$935
- Pfizer$420
- Lilly USA, LLC$310
- AstraZeneca$301
- Gilead$300
- plus $3K from 33 others
What the payments were for
- Food & beverage$6,036100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $1,125 |
| AbbVie | 45 | $935 |
| Pfizer | 20 | $420 |
| Lilly USA, LLC | 20 | $310 |
| AstraZeneca | 17 | $301 |
| Gilead | 12 | $300 |
| Merck | 14 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $279 |
| Corium, LLC | 12 | $278 |
| Amarin Pharma, Inc. | 9 | $182 |
| Exact Sciences | 8 | $168 |
| Dexcom, Inc. | 9 | $167 |
| Boehringer Ingelheim | 7 | $157 |
| Cranial Technologies, Inc | 7 | $120 |
| Amgen | 7 | $115 |
| GSK | 7 | $111 |
| Alk-abello, Inc | 4 | $105 |
| Supernus Pharmaceuticals, Inc. | 5 | $95 |
| Sanofi-aventis U.S. LLC | 3 | $68 |
| Corcept Therapeutics | 3 | $66 |
| Kaleo, Inc. | 4 | $65 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $35 |
| Eisai Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Bayer | 1 | $27 |
| Novartis | 1 | $24 |
| Seqirus USA Inc | 1 | $22 |
| Viiv Healthcare Company | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| BD | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| PBG Puerto Rico LLC | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$125
How this compares
$6,036 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- Rasheeta ChandlerTampa$37K
- Rosaly TorresTampa$28K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.